Market Moves: Strategy - Feb 15th, 2024
 
 
Corporate America is still investing
Market Moves: Strategy | View online
 
February 15, 2024
Investing for the long run

Last November, I headlined one of these newsletters with the phrase ‘Confidence curtailed’ to sum up the dominant sentiment I had been hearing from CEOs and CFOs on third-quarter earnings calls. Three and a half months on, it seems fair to upgrade that broad assessment to something along the (less pithy) lines of ‘Feeling good enough to keep investing.’ Executive teams don’t see many reasons in today’s economy to pull back from their mid- and long-term plans.

Goldman Sachs researchers last week published some numbers that speak to this: Among S&P 500 companies that have recently reported earnings, they noted, Q4 capex was flat versus a year earlier. The caveat: That was after spending had spiked 20% in 2022. Outlays on R&D, meanwhile, were up 10% from a year earlier — the same growth rate as in late 2022. Onward.

— Geert De Lombaerde
 

A booming ECD pipeline and more optimism from customers are driving the stronger outlook.
“We’re not going to just completely collapse ’24 investment at the risk of longer-term brand health.”
Solid overall growth and a large outpatient development pipeline will push spending past $5 billion.
“It’s just a matter of when,” Schneider’s Mark Rourke told analysts about price and demand dynamics.
Data points from various firms show a greater confidence in growth prospects.
Customers who endured price hikes may now expect reductions, but the data tells its own story.